Search results for "hypertrophy"

showing 10 items of 335 documents

Ventricular remodelling in rabbits with sustained high-fat diet.

2013

Aim Excess weight gain and obesity are one of the most serious health problems in the western societies. These conditions enhance risk of cardiac disease and have been linked with increased prevalence for cardiac arrhythmias and sudden death. Our goal was to study the ventricular remodelling occurring in rabbits fed with high-fat diet (HFD) and its potential arrhythmogenic mechanisms. Methods We used 15 NZW rabbits that were randomly assigned to a control (n = 7) or HFD group (n = 8) for 18 weeks. In vivo studies included blood glucose, electrocardiographic, and echocardiographic measurements. Optical mapping was performed in Langendorff-perfused isolated hearts. Results Body weight (3.69 ±…

Blood GlucoseMalemedicine.medical_specialtyPhysiologyAction PotentialsBiologyDiet High-FatWeight GainQT intervalSudden deathMuscle hypertrophyElectrocardiographyInternal medicineDiabetes mellitusmedicineRepolarizationAnimalsVentricular RemodelingArrhythmias CardiacHeartmedicine.diseaseObesitymedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2VentricleVentricular fibrillationCardiologyHypertrophy Left VentricularRabbitsActa physiologica (Oxford, England)
researchProduct

The effects of 12-week progressive strength training on strength, functional capacity, metabolic biomarkers, and serum hormone concentrations in heal…

2018

Previous findings suggest that performing strength training (ST) in the evening may provide greater benefit for young individuals. However, this may not be optimal for the older population. The purpose of this study was to compare the effects of a 12-week ST program performed in the morning vs. evening on strength, functional capacity, metabolic biomarker and basal hormone concentrations in older women. Thirty-one healthy older women (66 ± 4 years, 162 ± 4 cm, 75 ± 13 kg) completed the study. Participants trained in the morning (M) (07:30, n = 10), in the evening (E) (18:00, n = 10), or acted as a non-training control group (C) (n = 11). Both intervention groups performed whole-body strengt…

Blood Glucosemaximum strengthmedicine.medical_specialtyEveningWeight LiftingPhysiologyStrength trainingRestBlood lipidsMuscle hypertrophysenior fitness testsresistance03 medical and health sciencesFollicle-stimulating hormone0302 clinical medicinePhysiology (medical)Internal medicinemedicineHumanstime of the dayTestosteroneMuscle StrengthLeg pressMuscle Skeletalta315vuorokaudenajatMorningAgedblood lipidsbusiness.industryagingResistance Training030229 sport sciencesCircadian RhythmharjoitusvasteEndocrinologyikääntyminenFemalevoimaharjoitteluLuteinizing hormonebusiness030217 neurology & neurosurgeryBiomarkersikääntyneetChronobiology International
researchProduct

The Ketogenic Diet and Sport: A Possible Marriage?

2015

The ketogenic diet (KD) is used widely as a weight loss strategy and, more rarely, as therapy for some diseases. In many sports, weight control is often necessary (boxing, weightlifting, wrestling, etc.), but the KD usually is not considered. Our hypothesis is that KD might be used to achieve fat loss without affecting strength/power performance negatively.

Blood Glucosemedicine.medical_treatmentPhysiologyPhysical Therapy Sports Therapy and RehabilitationBody Mass Indexskeletal muscle hypertrophyDiet Carbohydrate-RestrictedWeight lossWeight LossmedicineHumansBody Fat DistributionOrthopedics and Sports MedicineMuscle StrengthMuscle SkeletalBody fat distributionSportendurancebusiness.industryMedicine (all)Power performanceWeight controlWeight Loendurance; ketogenic diet; skeletal muscle hypertrophy; strength; weight loss; Blood Glucose; Body Fat Distribution; Body Mass Index; Diet Carbohydrate-Restricted; Humans; Muscle Strength; Muscle Skeletal; Physical Endurance; Sports; Ketogenic Diet; Weight Loss; Orthopedics and Sports Medicine; Physical Therapy Sports Therapy and Rehabilitation; Medicine (all)ketogenic dietPhysical Endurancemedicine.symptombusinessDiet KetogenicstrengthBody mass indexFat lossKetogenic dietSportsHuman
researchProduct

Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy?

2021

Abstract It has long been known that blood pressure (BP) is characterized by marked short‐term fluctuations occurring within a 24‐h period and also by long‐term oscillations occurring over more prolonged periods of time. An increased short‐term blood pressure variability (BPV) appears to importantly contribute to target organ damage and to the enhanced cardiovascular risk of hypertensive patients, over and above the effect of an increase in mean BP levels. Reducing 24‐h mean BP is the main aim of antihypertensive therapy, but initial data are available that additional cardiovascular protection can be achieved by reducing BPV. However, to definitively prove the prognostic role of short‐term …

Blood pressure variabilityIntervention trialsmedicine.medical_specialtyAmbulatory blood pressureEndocrinology Diabetes and MetabolismBlood Pressure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHypertension generalHumansMedicine030212 general & internal medicineAntihypertensive Agentsbusiness.industryLeft ventricular hypertrophy (LVH) hypertensionBlood Pressure DeterminationAmbulatory blood pressureBlood Pressure Monitoring Ambulatoryhypertension—generalTarget organ damageOrgan damageAntihypertensive AgentBlood pressureHypertensionCommentaryCardiologyCardiology and Cardiovascular MedicinebusinessHumanThe Journal of Clinical Hypertension
researchProduct

Influence of metabolic syndrome on hypertension-related target organ damage

2005

Body surface areamedicine.medical_specialtyKidneybusiness.industryEnd organ damageLeft ventricular hypertrophymedicine.diseaseBioinformaticsEssential hypertensionEndocrinologymedicine.anatomical_structureHypertensive retinopathyDiabetes mellitusInternal medicineInternal MedicinemedicineMetabolic syndromebusinessAmerican Journal of Hypertension
researchProduct

Relationship between left ventricular hypertrophy, diastolic function and extracardiac atherosclerosis in newly diagnosed hypertensives

2001

Body surface areamedicine.medical_specialtyMegalencephalic leukoencephalopathy with subcortical cystsbusiness.industryDiastoleNewly diagnosedmedicine.diseaseLeft ventricular hypertrophyIntima-media thicknessmedicine.arteryInternal medicineInternal MedicineCardiologyMedicineDiastolic functionRadiologyCommon carotid arterybusinessAmerican Journal of Hypertension
researchProduct

Morphometric analysis of the parotid gland affected by alcoholic sialosis

2008

Background:  In alcoholic parotid sialosis, the gland is frequently enlarged due to ductal and/or acinar hypertrophy, ductal hyperplasy and stromal fat infiltration. The aim of this study was to determine acinar and ductal dimensions, the number of striated ducts and the proportion of fat tissue in patients with and without alcoholic parotid sialosis. Methods:  Twelve parotid biopsy samples from patients with hepatic alcoholic cirrhosis and those from seven controls were used. A morphometrical study with a digital image analyser attached to an optical microscope was carried out. Direct and indirect indicators from acinar and ductal dimensions were recorded. The number of striated ducts and …

Cancer ResearchAlcoholic liver diseasePathologymedicine.medical_specialtyStromal cellmedicine.diagnostic_testbusiness.industryAdipose tissuemedicine.diseaseSialadenitisPathology and Forensic MedicineMuscle hypertrophyParotid glandmedicine.anatomical_structurestomatognathic systemOtorhinolaryngologyMorphometric analysisBiopsymedicinePeriodonticsOral SurgerybusinessJournal of Oral Pathology & Medicine
researchProduct

Epulis granulomatosa as an oral manifestation of Klippel-Trénaunay syndrome

2006

The Klippel-Trenaunay syndrome (KTS) was first described by Klippel and Trenaunay in 1900. It is characterized by the triad of hemihypertrophy of soft and hard tissue, naevus flammeus and venous varicosity in the affected area. Though all oral tissues may be affected, only 5% of KTS show manifestations in the head and neck region. Only three cases are described with an oral manifestation, showing gingival overgrowth clinically and histologically corresponding to a pyogenic granuloma. It is still uncertain whether the combination of gingival fibromatosis and KTS is significant or coincidental. We report about a 25-year-old patient with KTS and recidivous gingival fibromatosis, clinically and…

Cancer ResearchPathologymedicine.medical_specialtyKlippel-Trenaunay syndromebusiness.industryEpulisVascular diseasePyogenic granulomaFibromatosisGingival fibromatosismedicine.diseasePathology and Forensic MedicineAngiomaOtorhinolaryngologyPeriodonticsMedicineOral SurgerybusinessHemihypertrophyJournal of Oral Pathology & Medicine
researchProduct

miR-133a Enhances the Protective Capacity of Cardiac Progenitors Cells after Myocardial Infarction

2014

Summary miR-133a and miR-1 are known as muscle-specific microRNAs that are involved in cardiac development and pathophysiology. We have shown that both miR-1 and miR-133a are early and progressively upregulated during in vitro cardiac differentiation of adult cardiac progenitor cells (CPCs), but only miR-133a expression was enhanced under in vitro oxidative stress. miR-1 was demonstrated to favor differentiation of CPCs, whereas miR-133a overexpression protected CPCs against cell death, targeting, among others, the proapoptotic genes Bim and Bmf. miR-133a-CPCs clearly improved cardiac function in a rat myocardial infarction model by reducing fibrosis and hypertrophy and increasing vasculari…

Cardiac function curveProgrammed cell deathMyocardial InfarctionGene ExpressionCardiomegalyBiologyBiochemistryArticleMuscle hypertrophyParacrine signallingDownregulation and upregulationmiR-133a; Cardiac Progenitors Cells; Myocardial InfarctionFibrosisREGENERATIONmicroRNAGeneticsmedicineMyocyteAnimalsRNA MessengerOXIDATIVE STRESSlcsh:QH301-705.5ENGINEERED HEART-TISSUElcsh:R5-920Gene Expression ProfilingMICRORNAComputational BiologyCell BiologyMUSCLEmedicine.disease3. Good healthCell biologyRatsAPOPTOSISHYPERTROPHYMicroRNAsDIFFERENTIATIONlcsh:Biology (General)ImmunologyGROWTHRNA Interferencelcsh:Medicine (General)EMBRYONIC STEM-CELLSMyoblasts CardiacDevelopmental BiologyStem Cell Reports
researchProduct

Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure

2008

AIMS: Recent studies have demonstrated the importance of chromatin remodelling via histone acetylation/deacetylation for the control of cardiac gene expression. Specific histone deacetylases (HDACs) can, in fact, play a positive or negative role in determining cardiac myocyte (CM) size. Here, we report on the effect on hypertrophy development of three inhibitors (HDACi) of class I HDACs. METHODS AND RESULTS: The compounds were first analysed in vitro by scoring hypertrophy, expression of foetal genes, and apoptosis of neonatal rat CMs stimulated with phenylephrine, an alpha1-adrenergic agonist. This initial screening indicated that a truncated derivative of apicidin with class I HDAC specif…

Cardiac function curvemedicine.medical_specialtyHypertrophy Heart failurePhysiologymedicine.drug_classBiologyPeptides CyclicHistone DeacetylasesCell LineMuscle hypertrophychemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineAnimalsHumansMyocytes CardiacEnzyme InhibitorsRats WistarCells CulturedHeart FailurePressure overloadHistone deacetylase inhibitorHypertrophic cardiomyopathyHypertrophymedicine.diseaseRatsHistone Deacetylase InhibitorsDisease Models AnimalEndocrinologychemistryEchocardiographyHeart failureHypertrophy Left VentricularHistone deacetylaseCardiology and Cardiovascular MedicineApicidinCardiovascular Research
researchProduct